, Volume 44, Issue 2, pp 496–503

Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation

  • Nadine A. Binai
  • Gert Carra
  • Johannes Löwer
  • Roswitha Löwer
  • Silja Wessler
Original Article

DOI: 10.1007/s12020-013-9897-y

Cite this article as:
Binai, N.A., Carra, G., Löwer, J. et al. Endocrine (2013) 44: 496. doi:10.1007/s12020-013-9897-y


In postmenopausal women, adipositas represents a serious risk factor for cancer development and progression. White adipose tissue secretes the 16 kDa hormone leptin which plays a key role in the regulation of appetite and metabolism. An increasing number of reports indicate that leptin also interferes with signal transduction pathways implicated in the development of breast cancer. In our previous study, we identified the estrogen receptor alpha (ERα) as a relevant enhancer of leptin-induced signal transduction leading to transactivation of signal transducer and activator of transcription 3 (Stat3). The purpose of this study is the investigation of specific target gene expression in response to leptin-mediated Stat3 signaling. We performed a comprehensive microarray analysis of ERα-positive and ERα-negative MDA-MB-231 cells upon leptin treatment and identified 49 genes which showed a significant ERα-dependent regulation in leptin-treated MDA-MB-231 cells. There was no intersection with genes which were merely up- or downregulated by ERα expression and only 9 and 11 genes overlapping targets which were regulated by leptin stimulation either in ERα-expressing or ERα-negative MDA-MB-231 cells, respectively. To demonstrate the specificity, expression of three target genes was validated by quantitative real-time PCR. In conclusion, these data imply that leptin can induce a different set of target genes dependent on ERα expression, which might contribute to the development and progression of cancer diseases.


Leptin Estrogen receptor Whole genome microarray Breast cancer 



Estrogen receptor alpha


Leptin receptor


Signal transducer and activator of transcription 3

Supplementary material

12020_2013_9897_MOESM1_ESM.xlsx (25 kb)
Supplementary material 1 (XLSX 24 kb)
12020_2013_9897_MOESM2_ESM.xlsx (31 kb)
Supplementary material 2 (XLSX 31 kb)
12020_2013_9897_MOESM3_ESM.xlsx (23 kb)
Supplementary material 3 (XLSX 22 kb)
12020_2013_9897_MOESM4_ESM.xlsx (23 kb)
Supplementary material 4 (XLSX 23 kb)
12020_2013_9897_MOESM5_ESM.pptx (195 kb)
Supplementary material 5 (PPTX 195 kb)

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Nadine A. Binai
    • 1
    • 3
  • Gert Carra
    • 1
  • Johannes Löwer
    • 1
  • Roswitha Löwer
    • 1
  • Silja Wessler
    • 2
  1. 1.Paul-Ehrlich-InstituteLangenGermany
  2. 2.Division of MicrobiologyParis-Lodron University of SalzburgSalzburgAustria
  3. 3.Biomolecular Mass Spectrometry & Proteomics GroupUtrecht UniversityUtrechtThe Netherlands

Personalised recommendations